268 related articles for article (PubMed ID: 30178864)
1. Delirium tremens in an AUD patient after an intrathecal baclofen pump induced total alcohol abstinence.
Calvo ME; Gunnarsson T; Smith L; Hao M
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5371-5376. PubMed ID: 30178864
[TBL] [Abstract][Full Text] [Related]
2. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder.
Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O
J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755
[TBL] [Abstract][Full Text] [Related]
3. Management of high-dose intrathecal baclofen pump explant: A case report.
Belisle Haley C; Agrawal M; Newton K; Yeung B; Dayal R
Pain Pract; 2023 Sep; 23(7):847-850. PubMed ID: 37074774
[TBL] [Abstract][Full Text] [Related]
4. Cyproheptadine for intrathecal baclofen withdrawal.
Meythaler JM; Roper JF; Brunner RC
Arch Phys Med Rehabil; 2003 May; 84(5):638-42. PubMed ID: 12736874
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Stetkarova I; Brabec K; Vasko P; Mencl L
Pain Physician; 2015; 18(4):E633-41. PubMed ID: 26218954
[TBL] [Abstract][Full Text] [Related]
6. Suppression of alcohol delirium tremens by baclofen administration: a case report.
Addolorato G; Leggio L; Abenavoli L; DeLorenzi G; Parente A; Caputo F; Janiri L; Capristo E; Rapaccini GL; Gasbarrini G
Clin Neuropharmacol; 2003; 26(5):258-62. PubMed ID: 14520166
[TBL] [Abstract][Full Text] [Related]
7. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.
Addolorato G; Leggio L; Abenavoli L; Agabio R; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
Am J Med; 2006 Mar; 119(3):276.e13-8. PubMed ID: 16490478
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of severe alcohol withdrawal delirium with very high-dose diazepam (260-480 mg) administration.
Korkmaz ŞA; Aldemir E; Güleç Öyekçin D
Curr Med Res Opin; 2024 Mar; 40(3):517-521. PubMed ID: 38300249
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome.
Girish K; Vikram Reddy K; Pandit LV; Pundarikaksha HP; Vijendra R; Vasundara K; Manjunatha R; Nagraj M; Shruthi R
Biomed J; 2016 Feb; 39(1):72-80. PubMed ID: 27105601
[TBL] [Abstract][Full Text] [Related]
10. Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management.
Douglas AF; Weiner HL; Schwartz DR
J Neurosurg; 2005 Jun; 102(6):1133-6. PubMed ID: 16028775
[TBL] [Abstract][Full Text] [Related]
11. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
[TBL] [Abstract][Full Text] [Related]
12. Bladder stones - red herring for resurgence of spasticity in a spinal cord injury patient with implantation of Medtronic Synchromed pump for intrathecal delivery of baclofen - a case report.
Vaidyanathan S; Soni BM; Oo T; Hughes PL; Singh G; Watt JW; Sett P
BMC Urol; 2003 Mar; 3():3. PubMed ID: 12659647
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
[TBL] [Abstract][Full Text] [Related]
15. Identification and management of alcohol withdrawal syndrome.
Mirijello A; D'Angelo C; Ferrulli A; Vassallo G; Antonelli M; Caputo F; Leggio L; Gasbarrini A; Addolorato G
Drugs; 2015 Mar; 75(4):353-65. PubMed ID: 25666543
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.
Loubser PG; Narayan RK; Sandin KJ; Donovan WH; Russell KD
Paraplegia; 1991 Jan; 29(1):48-64. PubMed ID: 2023770
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study.
Dobrydnjov I; Axelsson K; Berggren L; Samarütel J; Holmström B
Anesth Analg; 2004 Mar; 98(3):738-44, table of contents. PubMed ID: 14980929
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
Lewis KS; Mueller WM
Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
[TBL] [Abstract][Full Text] [Related]
19. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
[TBL] [Abstract][Full Text] [Related]
20. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.
Colombo G; Addolorato G; Agabio R; Carai MA; Pibiri F; Serra S; Vacca G; Gessa GL
Neurotox Res; 2004; 6(5):403-14. PubMed ID: 15545024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
